Therefore, this study aimed to investigate whether the quantitative amount of Peroxiredoxin‐2 proteins that are candidates of tumor suppressor role as well as Haptoglobin and Alpha‐1 antitrypsin in patients with NSCLS can be biomarker candidate to early diagnosis of this cancer. The gene discussed is HP; the disease is cancer.